Announcing the launch of Allergy, Asthma & Clinical Immunology

Allergy, Asthma & Clinical
Immunology
, the official journal of the Canadian Society of Allergy and
Clinical Immunology
(CSACI), has now
commenced publication with BioMed Central, having transferred to our open access
publishing format with the aim of increasing the success of the
journal.
 
AACI aims to further the understanding and treatment of allergic
and immunologic disease by providing a platform for the dissemination of
research and reviews that help elucidate normal immune mechanisms and the ways
in which these mechanisms become dysfunctional. The launch articles include a discussion by Gilles et
al
regarding the
involvement of pollen associated lipid mediators (PALMS) in the allergic
response to pollen and a review by Sonia Michail assessing the evidence surrounding the benefits
of probiotic use in treating allergic disease.
 
Editor-in-Chief,
Richard Warrington explains in his inaugural Editorial "[The 
CSACI
is] one of the oldest medical
specialty societies in Canada and
dedicated to the advancement of the knowledge and practice of allergy, clinical
immunology, and asthma, and the provision of optimal patient care" and commenting on their decision to transfer the journal to BioMed
Central
"we, the Editors-in-Chief of AACI and the Board of
Directors of CSACI, have decided that our journal should become an open-access
journal because we believe that medical knowledge should be freely available to
all". 
 
For further information about the journal, please visit the journal website or
view the instructions for
authors
if you would like
to submit a manuscript.

View the latest posts on the On Biology homepage

Comments

By commenting, you’re agreeing to follow our community guidelines.

Your email address will not be published. Required fields are marked *